Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO – Get Free Report)’s share price passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.28 and traded as low as $0.21. Northwest Biotherapeutics shares last traded at $0.23, with a volume of 3,564,085 shares traded.
Northwest Biotherapeutics Stock Down 3.2 %
The company has a market capitalization of $314.24 million, a price-to-earnings ratio of -2.84 and a beta of -0.52. The business has a 50-day moving average price of $0.26 and a 200-day moving average price of $0.28.
About Northwest Biotherapeutics
Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient’s own immune system to attack cancer.
Featured Articles
- Five stocks we like better than Northwest Biotherapeutics
- What is diluted earnings per share (Diluted EPS)?
- 3 Buyable Stocks With Solid Bottoms Ready to Rebound
- What is Put Option Volume?
- Advantage+ Shopping: Meta’s Fast Growing $20 Billion AI-Ads Star
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Robotaxi News: What Tesla and Lyft Headlines Mean for Shares
Receive News & Ratings for Northwest Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northwest Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
